90 related articles for article (PubMed ID: 2281107)
21. Reduction-mediated technetium-99m labeling of monoclonal antibodies.
Mather SJ; Ellison D
J Nucl Med; 1990 May; 31(5):692-7. PubMed ID: 2341907
[TBL] [Abstract][Full Text] [Related]
22. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
Mock BH; Wellman HN
J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
[TBL] [Abstract][Full Text] [Related]
23. Radiolabeled monoclonal antibodies: radiochemical pharmacokinetic and clinical challenges.
Gobuty AH; Kim EE; Weiner RE
J Nucl Med; 1985 May; 26(5):546-8. PubMed ID: 3989609
[No Abstract] [Full Text] [Related]
24. Use of polyclonal IgG in HIV infection and AIDS.
Buscombe JR; Oyen WJ; Corstens FH
Q J Nucl Med; 1995 Sep; 39(3):212-20. PubMed ID: 7552944
[TBL] [Abstract][Full Text] [Related]
25. Physiologic imaging of radiolabeled leukocytes.
Datz FL
Am J Physiol Imaging; 1987; 2(4):196-207. PubMed ID: 3330453
[TBL] [Abstract][Full Text] [Related]
26. A convenient method for the preparation of fluorous tin derivatives for the fluorous labeling strategy.
McIntee JW; Sundararajan C; Donovan AC; Kovacs MS; Capretta A; Valliant JF
J Org Chem; 2008 Nov; 73(21):8236-43. PubMed ID: 18826327
[TBL] [Abstract][Full Text] [Related]
27. Investigations of directly labeling antibodies with rhenium-188.
Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 1996 Jun; 40(2):151-60. PubMed ID: 8909100
[TBL] [Abstract][Full Text] [Related]
28. Strategies for labeling monoclonal antibodies and antibody-like molecules with technetium-99m.
Delmon-Moingeon LI; Mahmood A; Davison A; Jones AG
J Nucl Biol Med (1991); 1991; 35(1):47-59. PubMed ID: 1932176
[No Abstract] [Full Text] [Related]
29. Technetium-99m labeled mouse-spleen leukocytes: radiolabeling parameters--II.
Dettman GL; Wilbur SM; Vandenburg BL
Int J Appl Radiat Isot; 1980 Apr; 31(4):217-22. PubMed ID: 7380579
[No Abstract] [Full Text] [Related]
30. Direct 99mTc-labeling of antibodies by sodium dithionite reduction, and role of ascorbate as a stabilizer in cysteine challenge.
Qi P; Muddukrishna SN; Torok-Both R; Rahn J; Chen A
Nucl Med Biol; 1996 Aug; 23(6):827-35. PubMed ID: 8940727
[TBL] [Abstract][Full Text] [Related]
31. Tin-absorbed resin for the preparation of 99mTc-radiopharmaceuticals: stable complex of 99mTc-bleomycin.
Horiuchi K; Yokoyama A; Fujibayashi Y; Tanaka H; Odori T; Saji J; Morita R; Torizuka K
Int J Appl Radiat Isot; 1981 Jan; 32(1):47-52. PubMed ID: 6162804
[No Abstract] [Full Text] [Related]
32. Future directions in radiolabelling leucocytes--their substituents and their microenvironment.
McAfee JG
Nucl Med Commun; 1988 Oct; 9(10):775-81. PubMed ID: 3062509
[No Abstract] [Full Text] [Related]
33. An improved method for analysis of technetium radiolabeled antibody by size exclusion HPLC.
Muddukrishna SN; Jorge P; Machner W; Sykes TR; Noujaim AA
Appl Radiat Isot; 1994 Oct; 45(10):1009-19. PubMed ID: 7994287
[TBL] [Abstract][Full Text] [Related]
34. A comparison of four techniques for labeling albumin microspheres with technetium-99m.
Mayron LW; Kaplan E
Int J Nucl Med Biol; 1975 Mar; 2(2):74-80. PubMed ID: 1176265
[No Abstract] [Full Text] [Related]
35. Factors affecting the labeling of human fibrinogen with 99mTc in vitro.
Lavie E; Shenberg C; Bitton M; Mechlis S
Int J Appl Radiat Isot; 1984 Feb; 35(2):99-102. PubMed ID: 6706430
[TBL] [Abstract][Full Text] [Related]
36. Interaction of stannous ion with pyrrolidino-methyl tetracycline (PMT) in the preparation of PMT-99mTc radiopharmaceuticals.
Zmbova B; Zivanov-Stakić D; Tadzer I
Int J Appl Radiat Isot; 1981 Jul; 32(7):459-63. PubMed ID: 7263095
[No Abstract] [Full Text] [Related]
37. The reaction of stannous ion with thiomalic acid in the preparation of 99mTc--thiomalate as a radiopharmaceutical.
Ikeda I; Sakaguchi T
Int J Appl Radiat Isot; 1977 Apr; 28(4):387-93. PubMed ID: 863534
[No Abstract] [Full Text] [Related]
38. Review of platelet labelling and kinetics.
Peters AM
Nucl Med Commun; 1988 Oct; 9(10):803-8. PubMed ID: 3062510
[No Abstract] [Full Text] [Related]
39. Optimization of biodistribution by introducing different chemical linkages between antibody and an indium-111 chelate.
Quadri SM; Paik CH; Reba RC; Hong WP
Cancer Treat Res; 1990; 51():201-13. PubMed ID: 1977445
[No Abstract] [Full Text] [Related]
40. Simplified cell labelling with indium-111 acetylacetone.
Sinn H; Silvester DJ
Br J Radiol; 1979 Sep; 52(621):758-9. PubMed ID: 497640
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
